Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIG Prophylaxis for COPD Exacerbations
NCT02690038Phase 2Completed
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Sep 2016
- Primary completion
- Nov 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of intravenous immunoglobulin G in chronic obstructive pulmonary disease (COPD), sponsored by Ottawa Hospital Research Institute. Started Sep 2016; status: completed.
02
Drugs
intravenous immunoglobulin G
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02690038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02690038.